Anebulo Pharmaceuticals, Inc.
ANEB
$1.14
$0.065.56%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 968.12% | -54.62% | -39.88% | -22.54% | -22.02% |
| Total Receivables | -87.45% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.07% | -24.38% | 84.98% | 30.29% | -67.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 684.48% | -44.06% | -34.68% | -21.21% | -24.66% |
|
|
|||||
| Total Current Assets | 684.48% | -44.06% | -34.68% | -21.21% | -24.66% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -11.81% | -10.56% | -9.56% | -8.72% | -- |
| Total Assets | 541.89% | -39.41% | -32.07% | -20.07% | -17.10% |
|
|
|||||
| Total Accounts Payable | 26.74% | 61.19% | -59.37% | 20.77% | -43.68% |
| Total Accrued Expenses | 76.38% | 204.32% | -83.34% | -10.00% | 361.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 54.39% | 118.42% | -74.21% | -0.33% | 41.45% |
|
|
|||||
| Total Current Liabilities | 54.39% | 118.42% | -74.21% | -0.33% | 41.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 54.39% | 118.42% | -74.21% | -0.33% | 41.45% |
|
|
|||||
| Common Stock & APIC | 22.34% | 0.41% | 0.26% | 0.22% | 1.28% |
| Retained Earnings | -3.64% | -3.36% | -2.11% | -2.65% | -4.55% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 688.03% | -50.20% | -23.53% | -23.15% | -22.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 688.03% | -50.20% | -23.53% | -23.15% | -22.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 688.03% | -50.20% | -23.53% | -23.15% | -22.13% |
|
|
|||||